Wooree Bio Co.,Ltd (KOSDAQ:082850)
South Korea · Delayed Price · Currency is KRW 1,907.00
0.00 (0.00%)
At close: Feb 13, 2026
Wooree Bio Co.,Ltd Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -13,989 | 4,743 | 15,581 | 21,822 | 33,156 | 16,841 |
Depreciation & Amortization | 27,229 | 27,531 | 31,850 | 36,194 | 35,557 | 38,845 |
Loss (Gain) From Sale of Assets | -846.61 | -317.61 | 187.34 | -117.01 | 206.37 | 9,019 |
Asset Writedown & Restructuring Costs | 2,193 | 2,327 | - | - | - | 52.45 |
Loss (Gain) From Sale of Investments | - | - | - | - | -188.71 | 1,865 |
Loss (Gain) on Equity Investments | 5.2 | 79.77 | 190.83 | 123.76 | 184.23 | -13.08 |
Stock-Based Compensation | 185.42 | 111.89 | 364.55 | 400.24 | 577.6 | 629.8 |
Provision & Write-off of Bad Debts | 2,054 | 150.23 | -755.19 | -406.89 | 1,272 | -231.97 |
Other Operating Activities | -11,846 | 3,596 | 1,660 | 16,805 | 13,164 | 8,371 |
Change in Accounts Receivable | -79,071 | 78,181 | -48,066 | 95,739 | 46,531 | -66,623 |
Change in Inventory | 33,508 | 491.06 | 6,751 | 21,742 | -12,218 | -8,038 |
Change in Accounts Payable | 121,049 | -61,166 | 27,377 | -129,941 | -50,832 | 64,139 |
Change in Other Net Operating Assets | -50,978 | -19,488 | -8,627 | -19,008 | -17,200 | 4,572 |
Operating Cash Flow | 29,501 | 36,240 | 26,515 | 43,353 | 50,208 | 69,427 |
Operating Cash Flow Growth | -40.24% | 36.68% | -38.84% | -13.65% | -27.68% | 5.51% |
Capital Expenditures | -23,334 | -81,951 | -10,497 | -13,268 | -11,620 | -17,259 |
Sale of Property, Plant & Equipment | 4,222 | 1,090 | 106.47 | 801.23 | 1,198 | 36,096 |
Sale (Purchase) of Intangibles | -854.77 | -1,172 | -68.93 | -157.01 | -1,145 | -839.69 |
Investment in Securities | 3,149 | 28,344 | 5,121 | -29,565 | -6,216 | -34,628 |
Other Investing Activities | 65.79 | -459.46 | -148.51 | -259.59 | -173.33 | -79.7 |
Investing Cash Flow | -16,662 | -54,058 | -5,498 | -42,453 | -17,816 | -11,400 |
Short-Term Debt Issued | - | 74,516 | 85,512 | 106,100 | 104,368 | 140,544 |
Long-Term Debt Issued | - | 43,681 | - | - | 7,878 | 8,000 |
Total Debt Issued | 89,967 | 118,197 | 85,512 | 106,100 | 112,246 | 148,544 |
Short-Term Debt Repaid | - | -74,076 | -99,608 | -119,159 | -94,896 | -159,572 |
Long-Term Debt Repaid | - | -15,827 | -16,148 | -9,138 | -22,638 | -24,555 |
Total Debt Repaid | -86,788 | -89,903 | -115,755 | -128,296 | -117,534 | -184,127 |
Net Debt Issued (Repaid) | 3,179 | 28,294 | -30,243 | -22,196 | -5,288 | -35,583 |
Issuance of Common Stock | - | 18.44 | 354.26 | 904.35 | 1,766 | - |
Other Financing Activities | -0 | -1,603 | 539.85 | 9.74 | -49.18 | -356.83 |
Financing Cash Flow | 3,179 | 26,709 | -29,349 | -21,282 | -3,571 | -35,939 |
Foreign Exchange Rate Adjustments | -2,966 | 377.03 | 2,462 | 601.25 | 1,419 | -3,009 |
Miscellaneous Cash Flow Adjustments | 0 | 0 | 0 | 0 | -0 | 0 |
Net Cash Flow | 13,051 | 9,268 | -5,871 | -19,781 | 30,240 | 19,078 |
Free Cash Flow | 6,167 | -45,711 | 16,018 | 30,085 | 38,588 | 52,167 |
Free Cash Flow Growth | - | - | -46.76% | -22.04% | -26.03% | 25.14% |
Free Cash Flow Margin | 0.57% | -3.69% | 1.27% | 2.22% | 2.50% | 3.21% |
Free Cash Flow Per Share | 130.63 | -963.15 | 337.94 | 647.10 | 806.13 | 1151.92 |
Cash Interest Paid | 4,675 | 4,656 | 5,831 | 4,843 | 4,116 | 6,219 |
Cash Income Tax Paid | 28,272 | 13,846 | 7,031 | 3,392 | 5,270 | 4,257 |
Levered Free Cash Flow | 15,461 | -48,458 | 10,249 | 18,074 | 18,010 | 51,768 |
Unlevered Free Cash Flow | 19,264 | -45,082 | 14,031 | 21,167 | 20,783 | 55,810 |
Change in Working Capital | 24,515 | -1,982 | -22,564 | -31,468 | -33,719 | -5,951 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.